Stem cell populations and methods of use

Details for Australian Patent Application No. 2004316477 (hide)

Owner Aldagen, Inc.

Inventors Foster, Sandra J.; Gentry, Tracy; Balber, Andrew E.

Agent Spruson & Ferguson

Pub. Number AU-B-2004316477

PCT Pub. Number WO2005/083061

Priority 60/544,038 12.02.04 US; 60/543,607 11.02.04 US

Filing date 4 May 2004

Wipo publication date 9 September 2005

Acceptance publication date 7 October 2010

International Classifications

C12N 5/0789 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Stem cells

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

C12N 5/078 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells from blood or from the immune system

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/083061 Priority application(s): WO2005/083061

7 October 2010 Application Accepted

  Published as AU-B-2004316477

3 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004316481-Desalination scale inhibitors

2004316476-Piperidinyl targeting compounds that selectively bind integrins